Newark, CA, August 2021, ViOptix Inc. announces its Intra.Ox System receives FDA clearance.
The Intra.Ox™ Handheld Tissue Oximeter is intended to non-invasively estimate the percent oxygen saturation (StO2) in a volume of tissue.
In 2013, ViOptix received the prestigious Frost & Sullivan Best Practices Award recognizing superior leadership, technological innovation, customer service, and strategic product development. The company is headquartered in Newark, California.
Contact: info@ViOptix.com
ViOptix Announces FDA Clearance of Intra.Ox System for Assessment of...
READ FULLA New Diagnostic Algorithm for Early Prediction of Vascular Compromise...
READ FULLTissue Oximetry Monitoring in Microsurgical Breast Reconstruction Decreases Flap Loss...
READ FULLThree-Year Experience Using Near Infrared Spectroscopy Tissue Oximetry Monitoring of...
READ FULL